RGD-RE-1 Bifunctional Short Peptide Enhances the Interaction Between Rare Earth Nanomaterials and Cancer Cells and the Effect of Cell Autophagy

Author(s):  
Yunjiao Zhang
2018 ◽  
Vol 838 ◽  
pp. 129-137
Author(s):  
Hongjiao Liu ◽  
Xiaomian Lin ◽  
Tao Huang ◽  
Li Song ◽  
Cairong Zhu ◽  
...  

2017 ◽  
Vol 16 (01) ◽  
pp. 1650023
Author(s):  
Alexandra M. Brown ◽  
Yoliem S. Miranda-Alarćon ◽  
Grant A. Knoll ◽  
Anthony M. Santora ◽  
Ipsita A. Banerjee

In this work, self-assembled tumor targeting nanostructured surfaces were developed from a newly designed amphiphile by conjugating boc protected isoleucine with 2,[Formula: see text] ethylenedioxy bis ethylamine (IED). To target mouse mammary tumor cells, a short peptide sequence derived from the human alpha-fetoprotein (AFP), LSEDKLLACGEG was attached to the self-assembled nanostructures. Tumor targeting and cell proliferation were examined in the presence of nanoscale assemblies. To further obliterate mouse breast tumor cells, the chemotherapeutic drug tamoxifen was then entrapped into the nanoassemblies. Our studies indicated that the targeting systems were able to efficiently encapsulate and release tamoxifen. Cell proliferation studies showed that IED-AFP peptide loaded with tamoxifen decreased the proliferation of breast cancer cells while in the presence of the IED-AFP peptide nanoassemblies alone, the growth was relatively slower. In the presence of human dermal fibroblasts however cell proliferation continued similar to controls. Furthermore, the nanoscale assemblies were found to induce apoptosis in mouse breast cancer cells. To examine live binding interactions, SPR analysis revealed that tamoxifen encapsulated IED-AFP peptide nanoassemblies bound to the breast cancer cells more efficiently compared to unencapsulated assemblies. Thus, we have developed nanoscale assemblies that can specifically bind to and target tumor cells, with increased toxicity in the presence of a chemotherapeutic drug.


2017 ◽  
Vol 24 (1) ◽  
pp. 161-165 ◽  
Author(s):  
Luca Roncati ◽  
Antonietta Morena Gatti ◽  
Giuseppe Barbolini ◽  
Francesco Piscioli ◽  
Teresa Pusiol ◽  
...  

Biomaterials ◽  
2010 ◽  
Vol 31 (4) ◽  
pp. 714-729 ◽  
Author(s):  
Sonali Setua ◽  
Deepthy Menon ◽  
Adersh Asok ◽  
Shantikumar Nair ◽  
Manzoor Koyakutty

Author(s):  
Chavez-Garca D. ◽  
Juarez-Moreno K. ◽  
Campos C. H. ◽  
Alderete J. B. ◽  
Hirata G. A.

2019 ◽  
Vol 11 (12) ◽  
pp. 1806-1815
Author(s):  
Dan Zhou ◽  
Lei Zhou ◽  
Xiaoyan Hu ◽  
Yan Hu ◽  
Ping Hu

As a kind of rare earth fluorescent material, the rare earth upconversion nanomaterial can be applied in various fields such as biological detection and imaging, solar cells, and safe positioning, which has attracted wide concerns. In this study, the novel material is applied to the preparation of biological nano-fluorescent probes. Due to its broad UV absorption spectrum, cobalt oxyhydroxide is selected and used as a quencher for upconversion nanomaterials. Once the cobalt oxyhydroxide is placed on upconversion nanomaterials, the surface reaction can effectively remove the fluorescence reaction of the upconversion nanomaterial. In terms of the molecular miRNA tests for cells and living organisms, the nano-fluorescent probe can reduce the fluorescence intensity of miRNA, while the control group can finish the normal fluorescence reaction. The designed fluorescent probe can adjust the contents of cobalt oxyhydroxides and cells to regulate the fluorescence intensity. In terms of the miRNA sensitivity tests, the fluorescence intensity detected by the nano-fluorescent probe is significantly lower than that in the control group, which can be observed through the fluorescence recovery tests of the chemical system. After the addition of miRNA obtained from cells or living organisms, the fluorescent probe has apparently changed the fluorescence intensity of miRNA in cells/living organisms. Also, the detection range of miRNA is effectively expanded, i.e., the different concentrations of miRNA can be detected by adjusting the ratio of the components of the fluorescent probes, which indicates the excellent sensitivity of the fluorescent probe in detecting miRNA in cells and living organisms. In terms of the miRNA tests for cells, different degrees of cancer cells are selected. The fluorescent probe can discriminate the concentration of cancer cells according to fluorescence imaging of cancer cells, thereby further explaining that the fluorescent probe has high-sensitivity in bio-detection.


2019 ◽  
Vol 30 (10) ◽  
pp. 973-982
Author(s):  
Yi-shan Huang ◽  
Tian-xiang Wang ◽  
Xiao-mian Lin ◽  
Heng Wang ◽  
Rong-zhen Li ◽  
...  

2020 ◽  
Vol 17 (3) ◽  
pp. 427-433
Author(s):  
Le Nhat Minh ◽  
Vo Trong Nhan ◽  
Nguyen Thi Nga ◽  
Tran Thu Huong ◽  
Phung Thi Kim Hue ◽  
...  

Nanotechnology is the key technology that brings many important applications in biomedical research.Nanolantanites present high stability, easy fabrication and functionalization. Tb3+ ion-containing nanomaterial, a specific type of nanolantanites, possess great prospects. In addition, cancer stem cells (CSCs) are directlyrelated to drug resistance, metastasis, recurrent cancer, etc. Therefore, CSCs are considered as the target forcancer researching and for discovery of more effective therapies. CD133, a trans-membrane glycoprotein, isone of the typical markers that are found to appear very commonly on the surface of many types of CSCs. Inthis study, CD133 monoclonal antibody (MAb) was cojugated with nanomaterials containing Tb3+. Thecoupling between fluorescented nanomaterials containing Tb3+ ions and CD133 MAb was then incubated withhuman colon cancer cells (HT-29) to evaluate its ability to label CSCs in vitro. The results showed thatnanorods containing rare-earth based Tb3+ ions which were fabricated by hydrothermal method, present thelength of about 300 - 800 nm and the diameter in range of 40 - 50 nm. The Tb3+ nanoparticals also havehexagonal structure of terbium phosphate monohydrate and green illuminant. Tb3+ nanorods were also furthersurface silica coated and amino-silane functionalized. This nanostructure was successfully combined withmonoclonal antibodies against CD133 which labelled the surface marker of HT-29 human colon cancer cells.As a result, the combination of CD133+TbPO4@Silica-NH2 (functionalized surface) showed strongerluminescence than the CD133+TbPO4 unfunctionalized combination.


2017 ◽  
Vol 33 (2) ◽  
pp. 191-200 ◽  
Author(s):  
Dalia Chávez-García ◽  
Karla Juárez-Moreno ◽  
Cristian H. Campos ◽  
Joel B. Alderete ◽  
Gustavo A. Hirata

Abstract


Sign in / Sign up

Export Citation Format

Share Document